, Volume 188, Issue 4, pp 301–307 | Cite as

Continuous Positive Airway Pressure Improves Sleep Apnea Associated Fatty Liver

  • Isaac Shpirer
  • Laurian Copel
  • Efrat Broide
  • Arnon Elizur


Treatment of sleep apnea can improve liver enzyme abnormalities in patients with nonalcoholic fatty liver disease. However, the effect of continuous positive airway pressure therapy for sleep apnea on liver fat accumulation was not assessed. Liver biopsy is the “gold standard” for determining and quantifying liver fat accumulation; however, obtaining two separate liver biopsies is challenging. We examined, using a newly described computerized tomography method to quantify liver fat accumulation, whether treatment of sleep apnea improves liver steatosis. In a prospective cohort study, patients diagnosed with obstructive sleep apnea, at Assaf Harofeh Medical Center’s sleep laboratory, were identified. Patients completed a questionnaire and underwent blood tests for liver enzymes and lipid profile, and computed tomography scans to determine the liver attenuation index. Patients with liver attenuation index ≤−10 (correlating with histological macrovesicular steatosis ≥30%) were treated with continuous positive airway pressure for 2–3 years. Subsequently, patients underwent repeat blood tests and tomography scans. Of 47 patients who were analyzed, 16 had a low liver attenuation index (≤−10). Patients with moderate–severe sleep apnea had worse liver attenuation index compared with patients with mild sleep apnea despite comparable body mass index and triglycerides levels. Patients who were compliant with 2–3 years of continuous positive airway pressure treatment demonstrated significant improvement in the mean liver attenuation index, whereas noncompliant patients did not. Patients with nonalcoholic fatty-liver disease may benefit from identification and treatment for obstructive sleep apnea because treatment may improve liver steatosis.


Hepatitis Liver cirrhosis Computed tomography Positive pressure respiration 


  1. 1.
    Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221–1231CrossRefPubMedGoogle Scholar
  2. 2.
    Abdelmalek MF, Diehl AM (2007) Nonalcoholic fatty liver disease as a complication of insulin resistance. Med Clin North Am 91:1125–1149, ixCrossRefPubMedGoogle Scholar
  3. 3.
    Charlton M (2004) Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol 2:1048–1058CrossRefPubMedGoogle Scholar
  4. 4.
    Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Rein J, Vela-Bueno A, Kales A (2001) Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 163:608–613PubMedGoogle Scholar
  5. 5.
    Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A (1998) Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 157:144–148PubMedGoogle Scholar
  6. 6.
    Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165:1217–1219CrossRefPubMedGoogle Scholar
  7. 7.
    Vgontzas AN, Bixler EO, Chrousos GP (2005) Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 9:211–224CrossRefPubMedGoogle Scholar
  8. 8.
    Singh H, Pollock R, Uhanova J, Kryger M, Hawkins K, Minuk GY (2005) Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease. Dig Dis Sci 50:2338–2343CrossRefPubMedGoogle Scholar
  9. 9.
    Tanné F, Gagnadoux F, Chazouillères O, Fleury B, Wendum D, Lasnier E, Lebeau B, Poupon R, Serfaty L (2005) Chronic liver injury during obstructive sleep apnea. Hepatology 41:1290–1296CrossRefPubMedGoogle Scholar
  10. 10.
    Norman D, Bardwell WA, Arosemena F, Nelesen R, Mills PJ, Loredo JS, Lavine JE, Dimsdale JE (2008) Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea. Sleep 31:121–126PubMedGoogle Scholar
  11. 11.
    Chin K, Nakamura T, Takahashi K, Sumi K, Ogawa Y, Masuzaki H, Muro S, Hattori N, Matsumoto H, Niimi A, Chiba T, Nakao K, Mishima M, Ohi M, Nakamura T (2003) Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients. Am J Med 114:370–376CrossRefPubMedGoogle Scholar
  12. 12.
    Limanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, Busuttil RW, Saab S, Lu DS (2004) Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 230:276–280CrossRefPubMedGoogle Scholar
  13. 13.
    Rechstchaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. UCLA Brain Information Service/Brain Research Institute, Los AngelesGoogle Scholar
  14. 14.
    American Sleep Disorders Association (1992) EEG arousals: scoring rules and examples. A preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep15:173–184Google Scholar
  15. 15.
    American Academy of Sleep Medicine Task Force (1999) Sleep-disordered breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:667–689Google Scholar
  16. 16.
    Park SH, Kim PN, Kim KW, Lee SW, Yoon SE, Park SW, Ha HK, Lee MG, Hwang S, Lee SG, Yu ES, Cho EY (2006) Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 239:105–112CrossRefPubMedGoogle Scholar
  17. 17.
    Williams R (2006) Global challenges in liver disease. Hepatology 44:521–526CrossRefPubMedGoogle Scholar
  18. 18.
    Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43(2 Suppl 1):S99–S112CrossRefPubMedGoogle Scholar
  19. 19.
    Fan JG, Zhu J, Li XJ, Chen L, Li L, Dai F, Li F, Chen SY (2005) Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 43:508–514CrossRefPubMedGoogle Scholar
  20. 20.
    Kallwitz ER, Herdegen J, Madura J, Jakate S, Cotler SJ (2007) Liver enzymes and histology in obese patients with obstructive sleep apnea. J Clin Gastroenterol 41:918–921CrossRefPubMedGoogle Scholar
  21. 21.
    Lee JY, Kim KM, Lee SG, Yu E, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ (2007) Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 47(2):239–244CrossRefPubMedGoogle Scholar
  22. 22.
    Torres DM, Harrison SA (2008) Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 134:1682–1698CrossRefPubMedGoogle Scholar
  23. 23.
    Andersen T, Gluud C, Franzmann MB, Christoffersen P (1991) Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol 12:224–229CrossRefPubMedGoogle Scholar
  24. 24.
    Day CP, James OF (1998) Steatohepatitis: a tale of two “hits”? Gastroenterology 114:842–845CrossRefPubMedGoogle Scholar
  25. 25.
    Dixon JB, Bhathal PS, O’Brien PE (2001) Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121:91–100CrossRefPubMedGoogle Scholar
  26. 26.
    Postic C, Girard J (2008) Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118:829–838CrossRefPubMedGoogle Scholar
  27. 27.
    McArdle N, Hillman D, Beilin L, Watts G (2007) Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 175:190–195CrossRefPubMedGoogle Scholar
  28. 28.
    Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11:183–190CrossRefPubMedGoogle Scholar
  29. 29.
    Polotsky VY, Patil SP, Savransky V, Laffan A, Fonti S, Frame LA, Steele KE, Schweizter MA, Clark JM, Torbenson MS, Schwartz AR (2009) Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity. Am J Respir Crit Care Med 179(3):228–234CrossRefPubMedGoogle Scholar
  30. 30.
    Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ (2002) The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123(3):745–750CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Isaac Shpirer
    • 1
    • 5
    • 6
  • Laurian Copel
    • 2
    • 6
  • Efrat Broide
    • 3
    • 4
    • 6
  • Arnon Elizur
    • 4
    • 5
    • 6
  1. 1.Institute of Pulmonary MedicineAssaf Harofeh Medical CenterZerifinIsrael
  2. 2.Department of RadiologyAssaf Harofeh Medical CenterZerifinIsrael
  3. 3.Institute of Gastroenterology, Liver Diseases and NutritionAssaf Harofeh Medical CenterZerifinIsrael
  4. 4.Department of PediatricsAssaf Harofeh Medical CenterZerifinIsrael
  5. 5.The Sleep LaboratoryAssaf Harofeh Medical CenterZerifinIsrael
  6. 6.Sackler Faculty of MedicineTel Aviv UniversityAvivIsrael

Personalised recommendations